Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellex Patient Treatment (CPT) is a leading German biotechnology company specializing in the collection, production, and development of cell-based products for advanced therapies. As a global leader in the field of allogeneic bone marrow and peripheral blood stem cell collections, the company operates one of the most experienced donation centers worldwide. Cellex provides comprehensive CDMO services, including the manufacturing of Advanced Therapy Medicinal Products (ATMPs) such as CAR-T cells for both clinical trials and commercial use. The company serves as a critical infrastructure partner for the international pharmaceutical industry, ensuring the high-quality supply of starting materials and finished cell products for life-saving treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPT Cellex Patient Treatment.